Abstract Details
|
Carlos R. Camara-Lemarroy, MD
(MS Clinic, Foothills Medical Center, University of calgary)
PRESENTER |
Dr. Camara-Lemarroy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for emd serono. Dr. Camara-Lemarroy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Dr. Camara-Lemarroy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for amgen. Dr. Camara-Lemarroy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for novartis. |
| No disclosure on file | |
| Rene Rodriguez | No disclosure on file |
| Idanis Berrios Morales, MD (University of Massachusetts Medical School) | Dr. Berrios Morales has nothing to disclose. |
| Carolina Ionete, MD (UMass Memorial) | Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH. |
| Peter N. Riskind, MD, PhD (UMASS Memorial Hlth Ctr/Dept of Neuro) | No disclosure on file |